Center for Structural Biology
SARS-CoV-2 protein blocks an essential step in host gene expression, new discovery finds
Feb. 17, 2021—Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19.
Borden Lacy named director of Vanderbilt’s Center for Structural Biology
Jan. 11, 2021—Borden Lacy, Edward and Nancy Fody Chair in Pathology and professor of biochemistry and pathology, microbiology and immunology, has been named director of the Vanderbilt Center for Structural Biology, effective Jan. 1.
Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease—too much of a good thing
Oct. 27, 2020—Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people.
Biology researchers capture shape-shifting delivery structures in body’s cellular “FedEx system”
Mar. 9, 2020—A new cellular biology study reports the first visualization of a unique shape-shifting structure in the human body which plays an important role in the timely delivery of fats and proteins.